UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 10-Q
☒
QUARTERLY Report Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
For the quarterly period ended December 31, 2024
OR
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Commission File Number 1-4383

ESPEY MFG. & ELECTRONICS CORP.
(Exact name of registrant as specified in its
charter)
New York | Trading Symbol | 14-1387171 |
(State of incorporation) | ESP | (I.R.S. Employer's Identification No.) |
233 Ballston Avenue, Saratoga
Springs, New York 12866
(Address of principal executive offices)
518-245-4400
(Registrant's telephone number, including area code)
Securities registered pursuant to Section 12(b)
of the Act
Title of each class | Trading Symbol | Name of each exchange on which registered |
Common Stock $.33-1/3 par value | ESP | NYSE American |
Indicate by check mark whether the registrant
(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements
for the past 90 days.
☒
Yes ☐ No
Indicate by check mark whether the registrant
has submitted electronically every Interactive Date File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during
the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
☒
Yes ☐ No
Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company:
☐ Large accelerated filer | ☐ Non-accelerated filer |
☐ Accelerated filer | ☒ Smaller reporting company |
| ☐ Emerging growth company |
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Securities Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as
defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No
At February 10, 2025, there were 2,796,758 shares outstanding of the
registrant's Common stock, $.33-1/3 par value.
ESPEY MFG. & ELECTRONICS CORP.
Quarterly Report on Form 10-Q
I N D E X
PART I: FINANCIAL INFORMATION
ESPEY MFG. & ELECTRONICS CORP.
Balance Sheets
December 31, 2024 (Unaudited) and June 30, 2024
| |
December 31, 2024 | | |
June 30, 2024 | |
ASSETS | |
| | |
| |
Cash and cash equivalents | |
$ | 8,027,478 | | |
$ | 4,351,970 | |
Investment securities | |
| 20,264,567 | | |
| 18,878,631 | |
Trade accounts receivable, less allowance for credit losses of $3,000 | |
| 6,993,840 | | |
| 6,635,490 | |
| |
| | | |
| | |
Inventories: | |
| | | |
| | |
Raw materials | |
| 1,813,168 | | |
| 1,693,448 | |
Work-in-process | |
| 689,757 | | |
| 1,645,973 | |
Costs related to contracts in process | |
| 15,109,021 | | |
| 15,904,588 | |
Total inventories | |
| 17,611,946 | | |
| 19,244,009 | |
| |
| | | |
| | |
Net deferred tax assets | |
| 864,449 | | |
| 895,154 | |
Prepaid expenses and other current assets | |
| 1,793,934 | | |
| 3,231,402 | |
Total current assets | |
| 55,556,214 | | |
| 53,236,656 | |
| |
| | | |
| | |
Property, plant and equipment, net | |
| 4,635,071 | | |
| 3,306,275 | |
Total assets | |
$ | 60,191,285 | | |
$ | 56,542,931 | |
| |
| | | |
| | |
LIABILITIES AND STOCKHOLDERS' EQUITY | |
| | | |
| | |
Accounts payable | |
$ | 2,662,701 | | |
$ | 3,751,209 | |
Accrued expenses: | |
| | | |
| | |
Salaries and wages | |
| 502,295 | | |
| 928,163 | |
Vacation | |
| 534,025 | | |
| 511,144 | |
ESOP payable | |
| 180,518 | | |
| — | |
Other | |
| 1,284,491 | | |
| 757,552 | |
Payroll and other taxes withheld | |
| 837 | | |
| 56,862 | |
Contract liabilities | |
| 9,875,627 | | |
| 9,043,422 | |
Income taxes payable | |
| 334,146 | | |
| 220,607 | |
Total current liabilities | |
| 15,374,640 | | |
| 15,268,959 | |
| |
| | | |
| | |
Total liabilities | |
| 15,374,640 | | |
| 15,268,959 | |
| |
| | | |
| | |
Commitments and contingencies (See Note 5) | |
| | | |
| | |
| |
| | | |
| | |
Common stock, par value $.33-1/3 per share | |
| | | |
| | |
Authorized 10,000,000 shares; Issued 3,129,874 shares as of December 31, 2024 and June 30, 2024. Outstanding 2,796,758 and 2,733,958 shares as of December 31, 2024 and June 30, 2024, respectively (includes 200,652 and 211,487 Unearned ESOP shares, respectively) | |
| 1,043,291 | | |
| 1,043,291 | |
Capital in excess of par value | |
| 24,851,718 | | |
| 23,930,428 | |
Accumulated other comprehensive gain | |
| 5,004 | | |
| 6,544 | |
Retained earnings | |
| 28,232,545 | | |
| 26,004,790 | |
| |
| 54,132,558 | | |
| 50,985,053 | |
| |
| | | |
| | |
Less: Unearned ESOP shares | |
| (3,868,093 | ) | |
| (3,868,093 | ) |
Cost of 333,116 and 395,916 shares of common stock in treasury as of December 31, 2024 and June 30, 2024, respectively | |
| (5,447,820 | ) | |
| (5,842,988 | ) |
Total stockholders’ equity | |
| 44,816,645 | | |
| 41,273,972 | |
| |
| | | |
| | |
Total liabilities and stockholders' equity | |
$ | 60,191,285 | | |
$ | 56,542,931 | |
The accompanying notes are an integral part of the financial statements.
ESPEY MFG. & ELECTRONICS CORP.
Statements of Comprehensive Income (Unaudited)
Three and Six Months Ended December 31, 2024 and
2023
| |
Three Months Ended | | |
Six Months Ended | |
| |
December 31, | | |
December 31, | |
| |
2024 | | |
2023 | | |
2024 | | |
2023 | |
| |
| | |
| | |
| | |
| |
Net sales | |
$ | 13,608,740 | | |
$ | 10,302,541 | | |
$ | 24,051,958 | | |
$ | 18,870,755 | |
Cost of sales | |
| 10,445,028 | | |
| 7,159,966 | | |
| 18,087,364 | | |
| 13,482,803 | |
Gross profit | |
| 3,163,712 | | |
| 3,142,575 | | |
| 5,964,594 | | |
| 5,387,952 | |
| |
| | | |
| | | |
| | | |
| | |
Selling, general and administrative expenses | |
| 1,139,275 | | |
| 1,049,690 | | |
| 2,220,944 | | |
| 2,073,371 | |
Operating income | |
| 2,024,437 | | |
| 2,092,885 | | |
| 3,743,650 | | |
| 3,314,581 | |
| |
| | | |
| | | |
| | | |
| | |
Other income | |
| | | |
| | | |
| | | |
| | |
Interest income | |
| 260,222 | | |
| 161,513 | | |
| 527,839 | | |
| 308,943 | |
Other | |
| 8,203 | | |
| 5,251 | | |
| 18,994 | | |
| 19,394 | |
Total other income | |
| 268,425 | | |
| 166,764 | | |
| 546,833 | | |
| 328,337 | |
| |
| | | |
| | | |
| | | |
| | |
Income before provision for income taxes | |
| 2,292,862 | | |
| 2,259,649 | | |
| 4,290,483 | | |
| 3,642,918 | |
| |
| | | |
| | | |
| | | |
| | |
Provision for income taxes | |
| 384,363 | | |
| 464,279 | | |
| 783,667 | | |
| 753,004 | |
| |
| | | |
| | | |
| | | |
| | |
Net income | |
$ | 1,908,499 | | |
$ | 1,795,370 | | |
$ | 3,506,816 | | |
$ | 2,889,914 | |
| |
| | | |
| | | |
| | | |
| | |
Other comprehensive income, net of tax: | |
| | | |
| | | |
| | | |
| | |
Unrealized (loss) gain on investment securities | |
| (9,232 | ) | |
| 3,622 | | |
| (1,540 | ) | |
| 5,417 | |
| |
| | | |
| | | |
| | | |
| | |
Total comprehensive income | |
$ | 1,899,267 | | |
$ | 1,798,992 | | |
$ | 3,505,276 | | |
$ | 2,895,331 | |
| |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | |
Net income per share: | |
| | | |
| | | |
| | | |
| | |
Basic | |
$ | 0.74 | | |
$ | 0.73 | | |
$ | 1.37 | | |
$ | 1.17 | |
Diluted | |
$ | 0.71 | | |
$ | 0.72 | | |
$ | 1.32 | | |
$ | 1.16 | |
| |
| | | |
| | | |
| | | |
| | |
Weighted average number of shares outstanding: | |
| | | |
| | | |
| | | |
| | |
Basic | |
| 2,583,307 | | |
| 2,478,588 | | |
| 2,554,622 | | |
| 2,474,340 | |
Diluted | |
| 2,707,542 | | |
| 2,499,210 | | |
| 2,653,890 | | |
| 2,492,499 | |
| |
| | | |
| | | |
| | | |
| | |
Dividends per share: | |
$ | 0.25 | | |
$ | 0.15 | | |
$ | 0.50 | | |
$ | 0.30 | |
The accompanying notes are an integral part of the financial statements.
Espey Mfg. & Electronics Corp.
Statements of Changes in Stockholders' Equity (Unaudited)
Three Months Ended December 31, 2024
| |
| | |
| | |
| | |
Accumulated | | |
| | |
| | |
| | |
| | |
| |
| |
| | |
| | |
Capital in | | |
Other | | |
| | |
| | |
| | |
Unearned | | |
Total | |
| |
Outstanding | | |
Common | | |
Excess of | | |
Comprehensive | | |
Retained | | |
Treasury | | |
Treasury | | |
ESOP | | |
Stockholders’ | |
| |
Shares | | |
Amount | | |
Par Value | | |
Gain | | |
Earnings | | |
Shares | | |
Amount | | |
Shares | | |
Equity | |
Balance as of September
30, 2024 | |
| 2,744,458 | | |
$ | 1,043,291 | | |
$ | 24,111,147 | | |
$ | 14,236 | | |
$ | 26,969,864 | | |
| 385,416 | | |
$ | (5,777,389 | ) | |
$ | (3,868,093 | ) | |
$ | 42,493,056 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Comprehensive income: | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Net income | |
| | | |
| | | |
| | | |
| | | |
| 1,908,499 | | |
| | | |
| | | |
| | | |
| 1,908,499 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Other comprehensive loss, net of tax of ($1,939) | |
| | | |
| | | |
| | | |
| (9,232 | ) | |
| | | |
| | | |
| | | |
| | | |
| (9,232 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Total comprehensive income | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| 1,899,267 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Stock options exercised | |
| 52,300 | | |
| | | |
| 649,030 | | |
| | | |
| | | |
| (52,300 | ) | |
| 329,569 | | |
| | | |
| 978,599 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Stock-based compensation | |
| | | |
| | | |
| 91,541 | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| 91,541 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Dividends paid on common stock
$0.25 per share | |
| | | |
| | | |
| | | |
| | | |
| (645,818 | ) | |
| | | |
| | | |
| | | |
| (645,818 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Balance as of December 31, 2024 | |
| 2,796,758 | | |
$ | 1,043,291 | | |
$ | 24,851,718 | | |
$ | 5,004 | | |
$ | 28,232,545 | | |
| 333,116 | | |
$ | (5,447,820 | ) | |
$ | (3,868,093 | ) | |
$ | 44,816,645 | |
The accompanying notes are an integral part of the financial statements.
Espey Mfg. & Electronics Corp.
Statements of Changes in Stockholders' Equity (Unaudited)
Six Months Ended December 31, 2024
| |
| | |
| | |
| | |
Accumulated | | |
| | |
| | |
| | |
| | |
| |
| |
| | |
| | |
Capital in | | |
Other | | |
| | |
| | |
| | |
Unearned | | |
Total | |
| |
Outstanding | | |
Common | | |
Excess of | | |
Comprehensive | | |
Retained | | |
Treasury | | |
Treasury | | |
ESOP | | |
Stockholders’ | |
| |
Shares | | |
Amount | | |
Par Value | | |
Gain | | |
Earnings | | |
Shares | | |
Amount | | |
Shares | | |
Equity | |
Balance as of June 30, 2024 | |
| 2,733,958 | | |
$ | 1,043,291 | | |
$ | 23,930,428 | | |
$ | 6,544 | | |
$ | 26,004,790 | | |
| 395,916 | | |
$ | (5,842,988 | ) | |
$ | (3,868,093 | ) | |
$ | 41,273,972 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Comprehensive income: | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Net income | |
| | | |
| | | |
| | | |
| | | |
| 3,506,816 | | |
| | | |
| | | |
| | | |
| 3,506,816 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Other comprehensive loss, net of tax of ($323) | |
| | | |
| | | |
| | | |
| (1,540 | ) | |
| | | |
| | | |
| | | |
| | | |
| (1,540 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Total comprehensive income | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| 3,505,276 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Stock options exercised | |
| 62,800 | | |
| | | |
| 728,257 | | |
| | | |
| | | |
| (62,800 | ) | |
| 395,168 | | |
| | | |
| 1,123,425 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Stock-based compensation | |
| | | |
| | | |
| 193,033 | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| 193,033 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Dividends paid on common stock
$0.50 per share | |
| | | |
| | | |
| | | |
| | | |
| (1,279,061 | ) | |
| | | |
| | | |
| | | |
| (1,279,061 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Balance as of December 31, 2024 | |
| 2,796,758 | | |
$ | 1,043,291 | | |
$ | 24,851,718 | | |
$ | 5,004 | | |
$ | 28,232,545 | | |
| 333,116 | | |
$ | (5,447,820 | ) | |
$ | (3,868,093 | ) | |
$ | 44,816,645 | |
The accompanying notes are an integral part of the financial statements.
Espey Mfg. & Electronics Corp.
Statements of Changes in Stockholders' Equity (Unaudited)
Three Months Ended December 31, 2023
| |
| | |
| | |
| | |
Accumulated | | |
| | |
| | |
| | |
| | |
| |
| |
| | |
| | |
Capital in | | |
Other | | |
| | |
| | |
| | |
Unearned | | |
Total | |
| |
Outstanding | | |
Common | | |
Excess of | | |
Comprehensive | | |
Retained | | |
Treasury | | |
Treasury | | |
ESOP | | |
Stockholders’ | |
| |
Shares | | |
Amount | | |
Par Value | | |
(Loss) Gain | | |
Earnings | | |
Shares | | |
Amount | | |
Shares | | |
Equity | |
Balance as of September 30, 2023 | |
| 2,706,633 | | |
$ | 1,043,291 | | |
$ | 23,373,388 | | |
$ | (634 | ) | |
$ | 22,591,316 | | |
| 423,241 | | |
$ | (6,013,701 | ) | |
$ | (4,273,378 | ) | |
$ | 36,720,282 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Comprehensive income: | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Net income | |
| | | |
| | | |
| | | |
| | | |
| 1,795,370 | | |
| | | |
| | | |
| | | |
| 1,795,370 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Other comprehensive income,
net of tax of $761 | |
| | | |
| | | |
| | | |
| 3,622 | | |
| | | |
| | | |
| | | |
| | | |
| 3,622 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Total comprehensive income | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| 1,798,992 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Stock-based compensation | |
| | | |
| | | |
| 75,502 | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| 75,502 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Dividends paid on common stock
$0.15 per share | |
| | | |
| | | |
| | | |
| | | |
| (370,947 | ) | |
| | | |
| | | |
| | | |
| (370,947 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Balance as of December 31, 2023 | |
| 2,706,633 | | |
$ | 1,043,291 | | |
$ | 23,448,890 | | |
$ | 2,988 | | |
$ | 24,015,739 | | |
| 423,241 | | |
$ | (6,013,701 | ) | |
$ | (4,273,378 | ) | |
$ | 38,223,829 | |
The accompanying notes are an integral part of the financial statements.
Espey Mfg. & Electronics Corp.
Statements of Changes in Stockholders' Equity (Unaudited)
Six Months Ended December 31, 2023
| |
| | |
| | |
| | |
Accumulated | | |
| | |
| | |
| | |
| | |
| |
| |
| | |
| | |
Capital in | | |
Other | | |
| | |
| | |
| | |
Unearned | | |
Total | |
| |
Outstanding | | |
Common | | |
Excess of | | |
Comprehensive | | |
Retained | | |
Treasury | | |
Treasury | | |
ESOP | | |
Stockholders’ | |
| |
Shares | | |
Amount | | |
Par Value | | |
(Loss) Gain | | |
Earnings | | |
Shares | | |
Amount | | |
Shares | | |
Equity | |
Balance as of June 30, 2023 | |
| 2,702,633 | | |
$ | 1,043,291 | | |
$ | 23,283,245 | | |
$ | (2,429 | ) | |
$ | 21,867,720 | | |
| 427,241 | | |
$ | (6,038,691 | ) | |
$ | (4,273,378 | ) | |
$ | 35,879,758 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Comprehensive income: | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Net income | |
| | | |
| | | |
| | | |
| | | |
| 2,889,914 | | |
| | | |
| | | |
| | | |
| 2,889,914 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Other comprehensive income,
net of tax of $1,138 | |
| | | |
| | | |
| | | |
| 5,417 | | |
| | | |
| | | |
| | | |
| | | |
| 5,417 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Total comprehensive income | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| 2,895,331 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Stock options exercised | |
| 4,000 | | |
| | | |
| 34,490 | | |
| | | |
| | | |
| (4,000 | ) | |
| 24,990 | | |
| | | |
| 59,480 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Stock-based compensation | |
| | | |
| | | |
| 131,155 | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| 131,155 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Dividends paid on common stock
$0.30 per share | |
| | | |
| | | |
| | | |
| | | |
| (741,895 | ) | |
| | | |
| | | |
| | | |
| (741,895 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Balance as of December 31, 2023 | |
| 2,706,633 | | |
$ | 1,043,291 | | |
$ | 23,448,890 | | |
$ | 2,988 | | |
$ | 24,015,739 | | |
| 423,241 | | |
$ | (6,013,701 | ) | |
$ | (4,273,378 | ) | |
$ | 38,223,829 | |
The accompanying notes are an integral part of the financial
statements.
ESPEY MFG. & ELECTRONICS CORP.
Statements of Cash Flows (Unaudited)
Six Months Ended December 31, 2024 and 2023
| |
December 31, 2024 | | |
December 31, 2023 | |
Cash Flows from Operating Activities: | |
| | | |
| | |
Net income | |
$ | 3,506,816 | | |
$ | 2,889,914 | |
| |
| | | |
| | |
Adjustments to reconcile net income to net cash provided by operating activities: | |
| | | |
| | |
Stock-based compensation | |
| 193,033 | | |
| 131,155 | |
Depreciation | |
| 219,126 | | |
| 233,526 | |
ESOP compensation expense | |
| 286,262 | | |
| 183,364 | |
Deferred income tax benefit | |
| 30,705 | | |
| (212,848 | ) |
Gain on disposal of property, plant and equipment | |
| — | | |
| (150 | ) |
Changes in assets and liabilities: | |
| | | |
| | |
Increase in trade accounts receivable | |
| (358,350 | ) | |
| (205,985 | ) |
Decrease in income taxes receivable | |
| — | | |
| 35,666 | |
Decrease in inventories | |
| 1,632,063 | | |
| 2,027,322 | |
Decrease in prepaid expenses and other current assets | |
| 1,437,468 | | |
| 385,089 | |
(Decrease) increase in accounts payable | |
| (1,088,509 | ) | |
| 892,011 | |
Decrease in accrued salaries and wages | |
| (425,868 | ) | |
| (382,530 | ) |
Increase (decrease) in vacation accrual | |
| 22,881 | | |
| (163,645 | ) |
Decrease in ESOP payable | |
| (105,744 | ) | |
| (70,093 | ) |
Increase in other accrued expenses | |
| 526,939 | | |
| 436,356 | |
Decrease in payroll and other taxes withheld | |
| (56,025 | ) | |
| (11,786 | ) |
Increase (decrease) in contract liabilities | |
| 832,205 | | |
| (457,836 | ) |
Increase in income taxes payable | |
| 113,539 | | |
| 229,625 | |
Net cash provided by operating activities | |
| 6,766,541 | | |
| 5,939,155 | |
| |
| | | |
| | |
Cash Flows from Investing Activities: | |
| | | |
| | |
Additions to property, plant and equipment | |
| (1,547,922 | ) | |
| (3,469,630 | ) |
Proceeds from grant award | |
| — | | |
| 968,722 | |
Proceeds from sale of property, plant and equipment | |
| — | | |
| 150 | |
Purchase of investment securities | |
| (14,007,475 | ) | |
| (13,410,242 | ) |
Proceeds from sale/maturity of investment securities | |
| 12,620,000 | | |
| 11,508,438 | |
Net cash used in investing activities | |
| (2,935,397 | ) | |
| (4,402,562 | ) |
| |
| | | |
| | |
Cash Flows from Financing Activities: | |
| | | |
| | |
Dividends on common stock | |
| (1,279,061 | ) | |
| (741,895 | ) |
Proceeds from exercise of stock options | |
| 1,123,425 | | |
| 59,480 | |
Net cash used in financing activities | |
| (155,636 | ) | |
| (682,415 | ) |
| |
| | | |
| | |
Increase in cash and cash equivalents | |
| 3,675,508 | | |
| 854,178 | |
Cash and cash equivalents, beginning of period | |
| 4,351,970 | | |
| 2,748,755 | |
Cash and cash equivalents, end of period | |
$ | 8,027,478 | | |
$ | 3,602,933 | |
| |
| | | |
| | |
Supplemental Schedule of Cash Flow Information: | |
| | | |
| | |
Income taxes paid | |
$ | 639,014 | | |
$ | 702,000 | |
The accompanying notes are an integral part of the financial statements.
ESPEY MFG. & ELECTRONICS CORP.
Notes to Financial Statements (Unaudited)
Note 1. Basis of Presentation
In the opinion of management the accompanying
unaudited financial statements contain all adjustments (consisting of normal recurring adjustments) necessary for a fair presentation
of the results for such periods. The results for any interim period are not necessarily indicative of the results to be expected for the
full fiscal year. Certain information and footnote disclosures normally included in financial statements prepared in accordance with United
States generally accepted accounting principles have been condensed or omitted. The preparation of these financial statements requires
us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure
of assets and liabilities. On an ongoing basis, we evaluate our estimates and judgments, including those related to revenue recognition,
inventories, income taxes, and stock-based compensation. Specific to inventories, including work-in-process and contracts in process,
management evaluates, quarterly, those estimates used in determining the cost to complete for each contract on Espey Mfg. & Electronics
Corp.’s (the “Company”) sales backlog. The change in estimates may affect the reported amount of inventories and gross
profit in the current or a future period and could result in the Company recording a loss contingency when a loss is determined to be
probable and reasonably estimated. Management bases its estimates on historical experience and on various other factors that are believed
to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying amounts of assets
and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions
or conditions. These financial statements should be read in conjunction with the Company's most recent audited financial statements included
in its report on Form 10-K for the year ended June 30, 2024. Certain reclassifications may have been made to the prior year financial
statements to conform to the current year presentation.
Note 2. Investment Securities
FASB Accounting Standards Codification (“ASC”)
820 establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable
inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:
| ▪ | Level 1: Quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity
has the ability to access as of the measurement date. |
| ▪ | Level 2: Significant other observable inputs other than Level 1 prices such as quoted prices for similar
assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable
market data. |
| ▪ | Level 3: Significant unobservable inputs that reflect a reporting entity’s own assumptions about
the assumptions that market participants would use in pricing an asset or liability. |
The carrying amounts of financial instruments,
including cash and cash equivalents, short term investments, accounts receivable, accounts payable and accrued expenses, approximated
fair value as of December 31, 2024 and June 30, 2024 because of the immediate or short-term maturity of these financial instruments.
Investment securities at December 31, 2024 and
June 30, 2024 consisted of certificates of deposit, municipal bonds and U.S. Treasury bills. The Company classifies investment securities
as available-for-sale which have been determined to be level 1 assets. The cost, gross unrealized gains, gross unrealized losses and fair
value of available-for-sale debt securities by major security type at December 31, 2024 and June 30, 2024 are as follows:
| |
| | |
Gross | | |
Gross | | |
| |
| |
Amortized | | |
Unrealized | | |
Unrealized | | |
Fair | |
| |
Cost | | |
Gains | | |
Losses | | |
Value | |
December 31, 2024 | |
| | |
| | |
| | |
| |
Certificates of deposit | |
$ | 19,028,000 | | |
$ | — | | |
$ | — | | |
$ | 19,028,000 | |
Municipal bonds | |
| 1,134,476 | | |
| 5,797 | | |
| (3,459 | ) | |
| 1,136,814 | |
U.S. Treasury bills | |
| 95,756 | | |
| 3,997 | | |
| — | | |
| 99,753 | |
Total investment securities | |
$ | 20,258,232 | | |
$ | 9,794 | | |
$ | (3,459 | ) | |
$ | 20,264,567 | |
| |
| | | |
| | | |
| | | |
| | |
June 30, 2024 | |
| | | |
| | | |
| | | |
| | |
Certificates of deposit | |
$ | 17,651,000 | | |
$ | — | | |
$ | — | | |
$ | 17,651,000 | |
Municipal bonds | |
| 709,059 | | |
| 5,824 | | |
| (3,313 | ) | |
| 711,570 | |
U.S. Treasury bills | |
| 510,288 | | |
| 5,773 | | |
| — | | |
| 516,061 | |
Total investment securities | |
$ | 18,870,347 | | |
$ | 11,597 | | |
$ | (3,313 | ) | |
$ | 18,878,631 | |
The portfolio is diversified and highly liquid
and primarily consists of investment grade fixed income instruments. At December 31, 2024, the Company did not have any investments in
individual securities that have been in a continuous loss position considered to be other than temporary.
As of December 31, 2024 and June 30, 2024, the
remaining contractual maturities of available-for-sale debt securities were as follows:
| |
Years to Maturity | | |
| |
| |
Less than | | |
One to | | |
| |
| |
One Year | | |
Five Years | | |
Total | |
December 31, 2024 | |
| | | |
| | | |
| | |
Available-for-sale | |
$ | 18,116,028 | | |
$ | 2,148,539 | | |
$ | 20,264,567 | |
| |
| | | |
| | | |
| | |
June 30, 2024 | |
| | | |
| | | |
| | |
Available-for-sale | |
$ | 17,889,582 | | |
$ | 989,049 | | |
$ | 18,878,631 | |
Note 3. Net Income per Share
Basic net income per share excludes dilution and
is computed by dividing net income available to common stockholders by the weighted average number of common shares outstanding for the
period. Diluted net income per share reflects the potential dilution that could occur if securities or other contracts to issue common
stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the income of the
Company. The computation of diluted net income per share excluded options to purchase 0 shares of our common stock for the three and six
months ended December 31, 2024 and 149,531 shares for the three and six months ended December 31, 2023, as the effect of including them
would be anti-dilutive. As unearned shares owned by the Company’s sponsored leveraged employee stock ownership plan (the “ESOP”)
are released or committed-to-be-released, the shares become outstanding for earnings-per-share computations.
The following table sets forth the reconciliation
of the numerators and denominators of the basic and diluted earnings per share computations for continuing operations for the six month
periods ended December 31:
| |
2024 | | |
2023 | |
Numerator: | |
| | | |
| | |
Net income | |
$ | 3,506,816 | | |
$ | 2,889,914 | |
Denominator: | |
| | | |
| | |
| |
| | | |
| | |
Basic EPS: | |
| | | |
| | |
Common shares outstanding, beginning of period | |
| 2,733,958 | | |
| 2,702,633 | |
Unearned ESOP shares | |
| (211,487 | ) | |
| (233,646 | ) |
Weighted average common shares issued during the period | |
| 29,384 | | |
| 2,523 | |
Weighted average ESOP shares earned during the period | |
| 2,767 | | |
| 2,830 | |
Denominator for basic earnings per common shares – | |
| | | |
| | |
Weighted average common shares | |
| 2,554,622 | | |
| 2,474,340 | |
| |
| | | |
| | |
Diluted EPS: | |
| | | |
| | |
Common shares outstanding, beginning of period | |
| 2,733,958 | | |
| 2,702,633 | |
Unearned ESOP shares | |
| (211,487 | ) | |
| (233,646 | ) |
Weighted average common shares issued during the period | |
| 29,384 | | |
| 2,523 | |
Weighted average ESOP shares earned during the period | |
| 2,767 | | |
| 2,830 | |
Weighted average dilutive effect of stock options | |
| 99,268 | | |
| 18,159 | |
Denominator for diluted earnings per common shares – | |
| | | |
| | |
Weighted average common shares | |
| 2,653,890 | | |
| 2,492,499 | |
Note 4. Stock Based Compensation
The
Company follows ASC 718 in establishing standards for the accounting for transactions in which an entity exchanges its equity instruments
for goods or services, as well as transactions in which an entity incurs liabilities in exchange for goods or services that are based
on the fair value of the entity’s equity instruments or that may be settled by the issuance of those equity instruments. ASC 718
requires that the cost resulting from all share-based payment transactions be recognized in the financial statements based on the fair
value of the share-based payment. ASC 718 establishes fair value as the measurement objective in accounting for share-based payment transactions
with employees, except for equity instruments held by employee share ownership plans.
Total stock-based compensation expense recognized
in the statements of comprehensive income for the three-month periods ended December 31, 2024 and 2023 was $91,541 and $75,502, respectively,
before income taxes. The amount of this stock-based compensation expense related to non-qualified stock options (“NQSOs”)
for the three-month periods ended December 31, 2024 and 2023 was $8,362 and $10,290, respectively. The deferred tax benefit related to
the NQSOs as of December 31, 2024 and 2023 was approximately $1,756 and $2,161, respectively. Total stock-based compensation expense recognized
in the statements of comprehensive income for the six-month periods ended December 31, 2024 and 2023 was $193,033 and $131,155, respectively,
before income taxes. The amount of this stock-based compensation expense related to NQSOs for the six-month periods ended December 31,
2024 and 2023 was $15,421 and $18,545, respectively. The deferred tax benefit related to the NQSOs as of December 31, 2024 and 2023 was
approximately $3,238 and $3,894, respectively. The remaining stock option expense in each year related to incentive stock options (“ISOs”)
which are not deductible by the Company when exercised, assuming a qualifying disposition and as such no deferred tax benefit was established
related to these amounts.
As of December 31, 2024, there was $423,041 of
unrecognized compensation cost related to stock option awards that is expected to be recognized as expense over the next 1.75 years, of
which $385,833 relates to ISOs and $37,208 relates to NQSOs. The total deferred tax benefit related to these awards is expected to be
$7,814.
The Company has one employee stock option plan
under which options or stock awards may be granted, the 2017 Stock Option and Restricted Stock Plan (the "2017 Plan"). The Board
of Directors may grant options to acquire shares of common stock to employees and non-employee directors of the Company at the fair market
value of the common stock on the date of grant. The maximum aggregate number of shares of Common Stock subject to options or awards to
non-employee directors is 133,000 and the maximum aggregate number of shares of Common Stock subject to options or awards granted to non-employee
directors during any single fiscal year is the lesser of 13,300 and 33 1/3% of the total number of shares subject to options or awards
granted in such fiscal year. The maximum number of shares subject to options or awards granted to any individual employee may not exceed
15,000 in a fiscal year. Generally, options granted have a two-year vesting period based on two years of continuous service and have a
ten-year contractual life. Option grants provide for accelerated vesting if there is a change in control. Shares issued upon the exercise
of options are from those held in Treasury. Options covering 400,000 shares are authorized for issuance under the 2017 Plan. As of December
31, 2024, options covering 87,375 shares have been exercised and options covering 307,656 shares are outstanding. Options covering 4,969
shares remain available for grant after factoring the cancelled shares, which are eligible to be re-granted. While no further grants of
options may be made under the Company’s 2007 Stock Option and Restricted Stock Plan, as of December 31, 2024, 27,600 options were
outstanding under such plan of which all are vested and exercisable.
ASC 718 requires the use of a valuation model
to calculate the fair value of stock-based awards. The Company has elected to use the Black-Scholes option valuation model, which incorporates
various assumptions including those for dividend yield, volatility, expected life and interest rates.
The table below outlines the weighted average
assumptions that the Company used to calculate the fair value of each option award for the six months ended December 31, 2024 and 2023.
| | December 31, 2024 | | | December 31, 2023 | |
Dividend yield | | | 3.79% | | | | 3.63% | |
Company’s expected volatility | | | 33.33% | | | | 31.20% | |
Risk-free interest rate | | | 4.35% | | | | 4.39% | |
Expected term | | | 5.1 yrs | | | | 5.3 yrs | |
Weighted average fair value per share of options granted during the period | | $ | 5.40 | | | $ | 4.03 | |
The Company declared and paid regular cash dividends
of $0.50 per share for the six months ended December 31, 2024 and paid $0.30 cash dividends for the six months ended December 31,
2023. Expected stock price volatility is based on the historical volatility of the Company’s stock. The risk-free interest rate
is based on the implied yield available on U.S. Treasury issues with an equivalent term approximating the expected life of the options.
The expected option term (in years) represents the estimated period of time until exercise and is based on actual historical experience.
The following table summarizes stock option activity
during the six months ended December 31, 2024:
| | Employee Stock Option Plans |
| | | | | | Weighted | | |
| | Number of | | Weighted | | Average | | |
| | Shares | | Average | | Remaining | | Aggregate |
| | Subject | | Exercise | | Contractual | | Intrinsic |
| | to Option | | Price | | Term | | Value |
Balance at July 1, 2024 | | | 322,056 | | | $ | 18.41 | | | | 6.59 | | | | | |
Granted | | | 76,500 | | | $ | 21.58 | | | | 9.52 | | | | | |
Exercised | | | (62,800 | ) | | $ | 17.89 | | | | — | | | | | |
Forfeited or expired | | | (500 | ) | | $ | 16.54 | | | | — | | | | | |
Outstanding at December 31, 2024 | | | 335,256 | | | $ | 19.23 | | | | 6.95 | | | $ | 3,661,427 | |
Vested or expected to vest at December 31, 2024 | | | 320,083 | | | $ | 19.19 | | | | 6.84 | | | $ | 3,507,361 | |
Exercisable at December 31, 2024 | | | 180,356 | | | $ | 19.26 | | | | 5.09 | | | $ | 1,964,248 | |
The aggregate intrinsic value in the table above
represents the total pretax intrinsic value (the difference between the closing sale price of the Company’s common stock as reported
on the NYSE American on December 31, 2024 and the exercise price, multiplied by the number of in-the-money options) that would have been
received by the option holders if all option holders had exercised their options on December 31, 2024. This amount changes based on the
fair market value of the Company’s common stock. The intrinsic value of options exercised during the six months ended December 31,
2024 and 2023 was $668,878 and $9,482, respectively.
The following table summarizes changes in non-vested stock options
during the six months ended December 31, 2024:
| |
Weighted Number | |
Average |
| |
of Shares | |
Grant Date |
| |
Subject | |
Fair Value |
| |
to Option | |
(per Option) |
Non-vested at July 1, 2024 | |
| 147,300 | | |
$ | 4.15 | |
Granted | |
| 76,500 | | |
$ | 5.40 | |
Vested | |
| (68,400 | ) | |
$ | 4.11 | |
Forfeited or expired | |
| (500 | ) | |
$ | 4.03 | |
Non-vested at December 31, 2024 | |
| 154,900 | | |
$ | 4.78 | |
Note 5. Commitments and Contingencies
The Company from time to time, enters into standby
letters of credit agreements with financial institutions primarily relating to the guarantee of future performance on certain contracts.
Contingent liabilities on outstanding standby letters of credit agreements aggregated to zero at December 31, 2024 and June 30, 2024.
The Company, as a U.S. Government contractor, is subject to audits, reviews, and investigations by the U.S. Government related to its
negotiation and performance of government contracts and its accounting for such contracts. Failure to comply with applicable U.S. Government
standards by a contractor may result in suspension from eligibility for award of any new government contract and a guilty plea or conviction
may result in debarment from eligibility for awards. The government may, in certain cases, also terminate existing contracts, recover
damages, and impose other sanctions and penalties. As a result of contract audits, the Company will determine a range of possible outcomes
and, in accordance with ASC 450 “Contingencies,” the Company will accrue amounts within a range that appears to be its best
estimate of a possible outcome. Adjustments are made to accruals, if any, periodically based on current information.
We are party to various litigation matters and
claims arising from time to time in the ordinary course of business. There are no pending litigation matters or claims which we believe
will have a material adverse effect on our business, financial condition, results of operations or cash flows.
The Company was awarded $7.4 million in funding
during the second quarter of fiscal year 2023 in support of facility and capital equipment upgrades for testing and qualification for
the United States Navy. The funding is part of the Navy’s investment to improve and sustain the Surface Combatant Industrial Base.
The work is being conducted on the Company’s property in Saratoga Springs, NY, with completion slated for the first quarter of calendar
year 2025. The Company expects to be paid within 30 days after the submission of three milestone invoices, but will not be paid for expenses
incurred in excess of the specified milestone payment limits. The Company will record the receipt of milestone payments received as a
reduction from the cost of the assets. The Company will have an initial cash outlay to satisfy income tax obligations arising from the
value of the milestone payments received. The cash outlay arising from federal income tax obligations is expected to be recaptured in
future periods. Until recaptured, estimated tax obligations associated with the receipt of milestone payments are recorded on the balance
sheet and included in deferred tax assets. As of December 31, 2024, net deferred tax assets include a deferred tax asset of $888,032 associated
with milestone reimbursements received totaling $4,228,722. Included in property, plant, and equipment at December 31, 2024 was $2,311,788
not yet reimbursed for facility and capital upgrades under the funding award, compared to $965,392 in spending not yet reimbursed included
in property, plant, and equipment at June 30, 2024. Included in accounts payable at December 31, 2024 was approximately $11,770 for facility
and capital upgrades eligible to be reimbursed under the funding award compared to $272,560 included in accounts payable at June 30, 2024.
In June 2024, the Company notified the third-party
administrator of the IBEW Local 1799 Pension Fund of its intention to withdraw permanently from the plan. As required by the Employee
Retirement Income Security Act “ERISA”, the Company is subject to a termination withdrawal liability. The recorded termination
withdrawal obligation at December 31, 2024 and June 30, 2024 totaled $561,852 and $772,157, respectively, shown within the accounts payable
balance on the Company’s balance sheets. The remaining liability of $561,852 is expected to be paid in the second half of fiscal
2025. As the Company was the only remaining contributing employer to the multiemployer pension plan, its withdrawal constitutes a mass
withdrawal termination. Final withdrawal calculations are contingent upon the availability of January 1, 2025 assets and the finalization
of December 31, 2024 liabilities as the withdrawal liability will need to be re-determined based on a December 31, 2024 measurement date.
The Company does not expect future adjustments to the established liability to have a material impact on the Company’s financial
statements. The cost of the withdrawal liability obligation is recorded in indirect overhead product costs, capitalized in inventory and
expensed through cost of sales based on shipments.
In December 2024, the Company was awarded $3.4
million in funding in support of facility and capital equipment upgrades. The funding is part of the Navy’s investment to improve
and sustain the Surface Combatant Industrial Base. The grant is expected to be in force through calendar year 2026. There are currently
no expenditures or amounts that are considered reimbursable under this grant.
Note 6. Revenue
The Company follows ASC 606 “Revenue from
Contracts with Customers” to determine the recognition of revenue. This standard requires entities to assess the products or services
promised in contracts with customers at contract inception to determine the appropriate unit at which to record revenues. Revenue
is recognized when control of the promised products or services is transferred to customers at an amount that reflects the consideration
to which the entity expects to be entitled to in exchange for those products or services.
Significant judgment is required in determining
the satisfaction of performance obligations. Revenues from our performance obligations are satisfied over time using the output method
which considers the appraisal of results achieved and milestones reached or units delivered based on contractual shipment terms, typically
shipping point. Revenue is recognized when, or as, the customer takes control of the product or services. The output method
best depicts the transfer of control to the customer as the output method represents work completed. Control is typically transferred
to the customer at the shipping point, as the Company has a present right to payment, the customer has legal title to the asset, the customer
has the significant risks and rewards of ownership of the asset, and in most instances the customer has accepted the asset.
Total revenue recognized for the three and six
months ended December 31, 2024 based on units delivered was $9,237,688 and $17,500,184, respectively, compared to $8,237,156 and $14,642,694
for the same period in fiscal year 2024. Total revenue recognized for the three and six months ended December 31, 2024 based on milestones
achieved was $4,371,052 and $6,551,774, respectively, compared to $2,065,385 and $4,228,061 for the same period in fiscal year 2024.
The Company offers a standard one-year product
warranty. Product warranties offered by the Company are classified as assurance-type warranties, which means the warranty only guarantees
that the good or service functions as promised. Based on this, the provided warranty is not considered to be a distinct performance obligation. The
impact of variable consideration has been considered but none identified which would be required to be allocated to the transaction price
as of December 31, 2024. Our payment terms are generally 30-60 days.
Contract liabilities were $9,875,627 and $9,043,422
as of December 31, 2024 and June 30, 2024, respectively. The increase in contract liabilities is primarily due to the advance collection
of cash on specific contracts, offset in part, by revenue recognized. Revenue recognized that was in contract liabilities in the beginning
of the fiscal year was $2,377,108 for the six months ended December 31, 2024. The Company used the practical expedient to expense incremental
costs incurred to obtain a contract when the contract term is less than one year.
The Company’s backlog at December 31, 2024
totaling approximately $120.1 million is currently estimated to be recognized in the following fiscal years: 16.6% in 2025; 37.4% in 2026;
7.6% in 2027, and 38.4% thereafter. The timing of supplier deliveries of material, production schedules, the completion of engineering
deliverables, among other factors, could cause these estimates to change.
Note 7. Recently Issued Accounting Standards
Recent Accounting Pronouncements Not Yet Adopted
In December 2023, FASB issued ASU 2023-09, “Income
Taxes (Topic 740): Improvements to Income Tax Disclosures,” to enhance the transparency and decision usefulness of income
tax disclosures. The amendments in ASU 2023-09 provide improvements primarily related to the rate reconciliation and income taxes paid
information included in income tax disclosures. The Company would be required to disclose additional information regarding reconciling
items equal to or greater than five percent of the amount computed by multiplying pretax income (loss) by the applicable statutory tax
rate. Similarly, the Company would be required to disclose income taxes paid (net of refunds received) equal to or greater than five percent
of total income taxes paid (net of refunds received). The amendments in ASU 2023-09 are effective for the annual period beginning July
1, 2025. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. The
Company will evaluate the impact of ASU 2023-09 on its financial statements.
In November 2023, the FASB issued ASU 2023-07, “Segment
Reporting (Topic 280): Improvements to Reportable Segment Disclosures,” which provides updates to qualitative and quantitative reportable
segment disclosure requirements, including enhanced disclosures about significant segment expenses and increased interim disclosure requirements,
among others. The amendments in ASU 2023-07 are effective for fiscal years beginning after December 15, 2023, and interim periods within
fiscal years beginning after December 15, 2024. Early adoption is permitted, and the amendments should be applied retrospectively. The
adoption of ASU 2023-07 is not expected to have a significant impact on the financial statements. The Company is currently evaluating
the impact of this new guidance on its financial statements.
Recent Accounting Pronouncements Adopted
None
Note 8. Employee
Stock Ownership Plan
The Company sponsors a leveraged employee stock
ownership plan (the "ESOP") that covers all nonunion employees who work 1,000 or more hours per year and are employed on June
30. The Company makes annual contributions to the ESOP equal to the ESOP's debt service less dividends on unallocated shares received
by the ESOP. All dividends on unallocated shares received by the ESOP are used to pay debt service. Dividends on allocated ESOP shares
are recorded as a reduction of retained earnings. As the debt is repaid, shares are released and allocated to active employees, based
on the proportion of debt service paid in the year. The Company accounts for its ESOP in accordance with FASB ASC 718-40. Accordingly,
the shares purchased by the ESOP are reported as Unearned ESOP shares in the balance sheets and the statements of changes in stockholders’
equity. As shares are released or committed-to-be-released, the Company reports compensation expense equal to the current average market
price of the shares, and the shares become outstanding for earnings-per-share (EPS) computations. ESOP compensation expense was $163,067
and $94,175 for the three-month periods ended December 31, 2024 and 2023, respectively. ESOP compensation expense was $286,262 and $183,364
for the six-month periods ended December 31, 2024 and 2023, respectively.
The ESOP shares as of December
31, 2024 and 2023 were as follows:
| |
December 31, 2024 | | |
December 31, 2023 | |
Allocated shares | |
| 385,641 | | |
| 440,801 | |
Committed-to-be-released shares | |
| 10,835 | | |
| 11,080 | |
Unreleased shares | |
| 200,652 | | |
| 222,565 | |
Total shares held by the ESOP | |
| 597,128 | | |
| 674,446 | |
Fair value of unreleased shares | |
$ | 6,049,658 | | |
$ | 4,161,966 | |
The Company may at times be required to repurchase
shares at the ESOP participants’ request at the shares’ fair market value. During the three and six months ended December
31, 2024 and 2023, the Company did not repurchase shares previously held by the ESOP.
The ESOP allows for eligible participants to take
whole share distributions from the Plan on specific dates in accordance with the provision of the Plan. Share distributions from the ESOP
during the six months ended December 31, 2024 and 2023 totaled 65,491 and 44,157 shares, respectively.
Item 2. Management's Discussion and Analysis of
Financial Condition and Results of Operations
Overview
Espey Mfg. & Electronics Corp. (“Espey”)
is a power electronics design and original equipment manufacturing (OEM) company with a long history of developing and delivering reliable
products for use in military and severe environment applications. Design, manufacturing, and testing is performed in our in-service 150,000+
square foot facility located at 233 Ballston Ave, Saratoga Springs, New York. Espey is classified as a “smaller reporting company”
for purposes of the reporting requirements under the Securities Exchange Act of 1934, as amended. Espey’s common stock is publicly-traded
on the NYSE American under the symbol “ESP.”
Espey began operations after incorporation in
New York in 1928. We strive to remain competitive as a leader in high power energy conversion and transformer solutions through the design
and manufacture of new and improved products by using advanced and “cutting edge” electronics technologies.
Espey is an ISO 9001:2015 and AS9100:2016 certified
manufacturer of power conversion, advanced magnetics and build to print specifications provided by the customer “build to print”
products for the rugged industrial and military marketplace. Our primary products are power supplies, power converters, filters, power
transformers, magnetic components, power distribution equipment, UPS systems, and antennas. The applications of these products include
AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.
Espey services include design and development
to specification, build to specifications provided by the customer “build to print”, design services, design studies, environmental
testing services, metal fabrication, painting services, and development of automatic testing equipment. Espey is vertically integrated,
meaning that the Company produces individual components (including inductors), populates printed circuit boards, fabricates metalwork,
paints, wires, qualifies, and fully tests items, mechanically, electrically and environmentally, in house. Portions of the manufacturing
and testing process are subcontracted to vendors from time to time.
The Company markets its products primarily through
its own direct sales organization and through outside sales representatives. Business is solicited from large industrial manufacturers
and defense companies, the government of the United States, foreign governments and major foreign electronic equipment companies. Espey
is also on the eligible list of contractors with the United States Department of Defense. We pursue opportunities for prime contracts
directly with the Department of Defense and are generally automatically solicited by Department of Defense procurement agencies for their
needs falling within the major classes of products produced by the Company. Espey contracts with the Federal Government under cage code
20950 as Espey Mfg. & Electronics Corp.
There is competition in all classes of products
manufactured by the Company, ranging from divisions of the largest electronic companies, to many small companies. The Company's sales
do not represent a significant share of the industry's market for any class of its products. The principal methods of competition for
electronic products of both a military and industrial nature include, among other factors, price, product performance, the experience
of the particular company and history of its dealings in such products.
Our business is not seasonal. However, the concentration
of our business in the rail industry, and in equipment for military applications and industrial applications, and our customer concentrations
expose us to on-going associated risks. These risks include, without limitation, fluctuating requirements for power supplies in the rail
industry, dependence on appropriations from the United States Government and the governments of foreign nations, program allocations,
the potential of governmental termination of orders for convenience, and the general strength of the industry sectors in which our customers
transact business.
Future procurement needs supporting the military
and the rail industry continue to drive competition. Many of our competitors have invested, and continue to invest, aggressively in upfront
product design costs and accept lower profit margins as a strategic means of maintaining existing business and enhancing market share.
This continues to put pressure on the pricing of our current products and has lowered our profit margins on some of our new business.
In order to compete effectively for new business, in some cases we have invested in upfront design costs, thereby reducing initial profitability
as a means of procuring new long-term programs. As part of our strategy, we adjust our pricing in order to achieve a balance which enables
us both to retain repeat programs while being more competitive in bidding on new programs.
Our sales strategy includes identifying and obtaining
multiple new engineering design and development contracts in any given fiscal year to ensure optimal utilization of our engineering personnel
in addition to securing follow-on production awards for product previously designed in-house, as well as, new or follow-on build to print
opportunities. The Company targets those programs and opportunities which will generate future longer-term production tails in ensuing
years. From time to time, we accept work associated with engineering design studies. While unlikely to result in near-term follow-on orders,
this positions us competitively for future awards and expands our engineering team’s skillset.
The total backlog at December 31, 2024 was approximately
$120.1 million, which included $78.3 million from three significant customers, compared to approximately $84.8 million at December 31,
2023, which included $57.4 million from five significant customers. The Company’s total backlog represents the estimated remaining
sales value of work to be performed under firm contracts. It is not uncommon to receive orders which include delivery schedules extending
beyond a year from the contract purchase date. Due to this, a customer’s future reorder point may vary. The backlog at December
31, 2024 is fully funded, except for approximately $20.4 million, representing two firm follow-on multi-year orders from a single customer.
While there is no guarantee that future budgets and appropriations will provide funding for individual programs, management has included
in the unfunded backlog only those programs that it believes are likely to receive funding based on program status and discussions with
customers. Contracts are subject to modification, change or cancellation, and the Company accounts for these changes as they are probable
and estimable. The Company evaluates the impact of any scope modifications and will adjust reserves to the extent information is known
or estimable.
Management expects revenues in fiscal year 2025
to be higher than revenues recognized during fiscal year 2024 but expects that net income per share will be lower than fiscal year 2024
net income per share, although greater than fiscal year 2023 net income per share. This expectation is driven primarily by orders already
in our backlog that will be shipped in fiscal year 2025 with higher anticipated aggregate costs than the product mix shipped during fiscal
year 2024.
From time to time, we encounter part
obsolescence which requires us to identify an alternate part suitable for use. We continue to work with our customers on strategies
to mitigate any adverse impact upon our ability to service their requirements. Factors which may arise after the placement of the
customer’s order may cause us to miss projected delivery dates. Inflationary costs are expected to continue, but are not
expected to have a significant impact on operating income in fiscal year 2025. Tariffs on steel and aluminum imports from various
countries continue to be in effect and the newly inaugurated President has announced the imposition of additional tariffs. Although
we are not currently experiencing any significant financial or raw material sourcing issues resulting from the product tariffs, the
Company cannot provide any assurance that the existing and newly-imposed tariffs, the potential of additional tariffs, and the
associated volatility arising from foreign trade policies, will not have a negative impact on our future earnings by increasing our
raw material prices and augmenting the lead time for the availability of raw materials.
The labor workforce remains stable. Management
continues to closely monitor workforce labor requirements to support our sales backlog and planned delivery schedules. Longer time-to-hire
challenges remain for certain positions due to specific skillsets required for those positions. Unemployment rates in the local geographic
region trend lower than the national average which has created a competitive recruiting environment. Where possible, the Company continues
to offer on-the-job training and when necessary, continues to recruit personnel outside the local region. Combined with supply chain constraints,
unforeseen labor disruptions could delay shipments and result in missing our backlog fulfillment projections and recognizing lower than
anticipated operating income.
Successful conversion of engineering program backlog
into sales is largely dependent on the execution and completion of our engineering design efforts. It is not uncommon to experience technical
or scheduling delays which arise from time to time as a result of, among other reasons, design complexity, the availability of personnel
with the requisite expertise, and the requirements to obtain customer approval at various milestones. Cost overruns which may arise
from technical and scheduling delays and increased raw material costs could negatively impact the timing of the conversion of backlog
into sales, or the profitability of such sales. Engineering programs in both the funded and unfunded portions of the current backlog aggregate
$9.6 million.
It is presently anticipated that a minimum of
$19.9 million of orders comprising the December 31, 2024 backlog will be filled during the fiscal year ending June 30, 2025 subject, however,
to the impact of the factors identified above. The minimum of $19.9 million does not include any shipments which may be made against orders
subsequently received during the fiscal year ending June 30, 2025.
The Company currently expects new orders in fiscal
year 2025 to be greater than those received in fiscal year 2024. New orders received in the first six months of fiscal year 2025 were
approximately $46.9 million as compared to approximately $20.1 million new orders received in the first six months of fiscal year 2024.
Included in new orders received during the current fiscal year is an award for $29.5 million, when fully funded, to provide electric power
distribution panels for the U.S. Navy’s Columbia class submarines through calendar year 2030. In addition to the backlog and the
new orders already booked in fiscal year 2025, the Company currently has outstanding opportunities representing approximately $113 million
in the aggregate as of February 4, 2025 for both repeat and new programs. Outstanding opportunities encompass various new and previously
manufactured power supplies, transformers, and subassemblies. We consider the value of those opportunities we believe are likely
to be awarded based on factors which include: quotation status, communicated award dates, historical ordering, public information on defense
programs and program funding, discussion with customers, and our cost competitiveness. However, there can be no assurance that the
Company will acquire any of the outstanding opportunities described above, many of which are subject to allocations of the United States
defense spending and factors affecting the defense industry. Also, many solicitations we receive for the procurement of goods and services
are associated with competitive bidding processes.
A significant portion of the Company’s business
is the production of military and industrial electronic equipment for use by the U.S. and foreign governments and certain industrial customers.
Net sales to four significant customers represented 62% of the Company’s total sales for the three-month period ended December 31,
2024. Net sales to five significant customers represented approximately 86% of the Company’s total sales for the three-month period
ended December 31, 2023. Net sales to five significant customers represented approximately 69% of the Company’s total sales for
the six-month period ended December 31, 2024. Net sales to five significant customers represented 82% of the Company’s total sales
for the six-month period ended December 31, 2023. A loss of one of these customers or programs related to these customers, or customer
requested deferrals of product delivery could significantly impact the Company.
Historically, a small number of customers have
accounted for a large percentage of the Company’s total sales in any given fiscal year. Management continues to pursue opportunities
with current and new customers with an overall objective of lowering the concentration of sales, mitigating excessive reliance upon a
single major product of a particular program and minimizing the impact of the loss of a single significant customer. Given the nature
of our business, we believe our existing sales order backlog is fairly diversified in terms of customers and the category of products
on order.
Critical Accounting Policies and Estimates
Management believes our most critical accounting
policies include revenue recognition and cost estimation on our contracts.
Revenue
The majority of our sales are generated from military
contracts from defense companies, the United States Department of Defense, other agencies of the government of the United States and foreign
governments, for the design and development and/or manufacture of products. Sales are also generated from industrial manufacturers for
similar services. We provide our products and design and development services under fixed-price contracts. Under fixed-price contracts
we agree to perform the specified work for a pre-determined price. To the extent our actual costs vary from the estimates upon which the
price was negotiated, we will generate more or less profit or could incur a loss.
We account for a contract with a customer after
it has been approved by all parties to the arrangement, the rights of the parties are identified, payment terms are identified, the contract
has commercial substance, and collection of substantially all of the amount to which the entity will be entitled in exchange for the goods
or services that will be transferred to the customer is probable. We assess each contract at its inception to determine whether it should
be combined with other contracts. When making this determination, we consider factors such as whether two or more contracts were negotiated
and executed at or near the same time, or were negotiated with an overall profit objective.
We evaluate the products or services promised
in each contract at inception to determine whether the contract should be accounted for as having one or more performance obligations.
Significant judgment is required in determining performance obligations. We determine the transaction price for each contract based on
the consideration we expect to receive for the products or services being provided under the contract. The transaction price for each
performance obligation is based on the estimated standalone selling price of the product or service underlying each performance obligation.
Transaction prices on our contracts subject to the Federal Acquisition Regulations (FAR) are typically based on estimated costs plus a
reasonable profit margin.
We recognize revenue using the output method based
on the appraisal of results achieved and milestones reached or units delivered based on contractual shipment terms, typically shipping
point.
Inventory
Raw materials are valued at the lower of cost
(average cost) or net realizable value. Balances for slow-moving and obsolete inventory are reviewed on a regular basis by analyzing estimated
demand, inventory on hand, sales levels, market conditions, and other information. Inventory balances are reduced based on this analysis.
Inventoried work relating to contracts in process
and work-in-process is valued at actual production cost, including factory overhead incurred to date. Contract costs include material,
subcontract costs, labor, and an allocation of overhead costs. Work-in-process represents spare units and parts and other inventory items
acquired or produced to service units previously sold or to meet anticipated future orders. Provision for losses on contracts is made
when the existence of such losses becomes probable and estimable. The provision for losses on contracts is included in other accrued
expenses on the Company’s balance sheet. The costs attributed to units delivered under contracts are based on the estimated
average cost of all units expected to be produced. Certain contracts are expected to extend beyond twelve months.
The estimation of total cost at completion of
a contract is subject to numerous variables involving contract costs and estimates as to the length of time to complete the contract. Given
the significance of the estimation processes and judgments described above, it is possible that materially different amounts of expected
sales and contract costs could be recorded if different assumptions were used, based on changes in circumstances, in the estimation process. When
a change in expected sales value or estimated cost is determined, the change is reflected in current period earnings.
Contract Liabilities
Contract liabilities include advance payments
and billings in excess of revenue recognized.
Accounts Receivable and Allowance for Credit Losses
The Company extends credit to its customers in
the normal course of business and collateral is generally not required for trade receivables. Exposure to credit risk is controlled
through the use of credit approvals, credit limits, and monitoring procedures. Accounts receivable are reported net of an allowance
for credit losses. The Company estimates the allowance based on its analysis of historical experience, current economic market conditions,
performance of specific account reviews, and other factored considerations to include, but not limited to, contracts covered by government
funding and the overall health of the industry. Interest is not charged on past due balances. Based on these factors, there was an allowance
for credit losses of $3,000 at December 31, 2024 and June 30, 2024. Changes to the allowance for credit losses are charged to expense
and reduced by charge-offs, net of recoveries. The opening accounts receivable balance, net of allowance for credit losses of $3,000,
at July 1, 2023 and July 1, 2024 were $5,755,282 and $6,635,490, respectively.
Results of Operations
Net sales for the three months ended December
31, 2024 and 2023 were $13,608,740 and $10,302,541, respectively, a 32.1% increase. Net sales for the six months ended December 31, 2024
and 2023 were $24,051,958 and $18,870,755, respectively, a 27.5% increase. In general, sales fluctuations may occur during comparable
fiscal periods as the direct result of sales backlog levels, product mix, and specific contractual terms of those firm orders placed including
contract value, scope of work, and contract delivery schedules.
For the three months ended December 31, 2024,
the increase in sales when compared to the same period last year is primarily due to more deliveries against an overall higher sales backlog
and the product mix comprising those shipments. The increase in sales in the current year was primarily related to product supporting
magnetics, power supply, and build to print contracts. During the current quarter, sales increased on deliveries for (i) a large follow-on
order for power distribution panels, (ii) a large follow-on order for inverters used on armored multi-purpose vehicles, and (iii) numerous
deliveries on build to print follow-on orders in which there were no sales in the comparable period last year. These increases were offset,
in part, by a decrease in deliveries for (i) a contract for power supplies supporting the AESA radar program and (ii) fewer sales on
an engineering development job which had fewer sales when compared to the same period last year.
For the six months ended December 31, 2024,
the increase in sales when compared to the same period last year is primarily due to more deliveries against an overall higher sales
backlog and the product mix comprising those shipments. The increase in sales in the current year was primarily related to product
supporting power supply, magnetics, and build to print contracts. For the six months ended December 31, 2024, sales increased on
deliveries for (i) a large follow-on order for power distribution panels, (ii) a large follow-on order for inverters used on armored
multi-purpose vehicles, (iii) deliveries on several follow-on orders for power supplies and overall build to print contracts, (iv)
shipments on a large multi-year magnetics contract for transformers, and (v) sales on a new engineering development contract in
which there were no comparable sales in the prior period. These increases were offset, in part, by a decrease in sales related to a
family of power distribution transformers for a single customer.
Gross profits for the three months ended December
31, 2024 and 2023 were $3,163,712 and $3,142,575, respectively. Gross profit as a percentage of sales was approximately 23.2% and 30.5%,
for the same periods, respectively. Gross profits for the six months ended December 31, 2024 and 2023 were $5,964,594 and $5,387,952,
respectively. Gross profit as a percentage of sales was approximately 24.8% and 28.6% for the same
periods, respectively.
Gross profits remained flat for the three months
ended December 31, 2024 when compared to the same period last year and increased for the six months ended December 31, 2024 when compared
to the same period last year. The decrease in the gross margin percentages for the three and six months ended December 31, 2024 when compared
to the same period last year primarily resulted from (i) product mix, specifically impacted by shipments on a large magnetics program
with lower gross margins, which management remains optimistic will improve as we work to achieve production efficiencies in the current
build process on this internally designed product which has only had a limited number of completed production builds to date, (ii) higher
than average profit margins on one-time sales to certain customers in the prior year, (iii) increased costs incurred with restarting a
production line for a large power supply contract which is expected to generate future additional re-order opportunities, and (iv) costs
incurred on a specific engineering development program.
The primary factors in determining the change
in gross profit and net income are overall sales levels and product mix. The gross profits on mature products and build to print contracts
are typically higher as compared to products which are still in the engineering development stage or in early stages of production. In
the case of the latter, the Company can incur what it refers to as “loss contracts,” primarily on engineering design contracts
in which the Company invests with the objective of developing future product sales. In any given accounting period the mix of product
shipments between higher margin programs and less mature programs, and expenditures associated with loss contracts, has a significant
impact on gross profit and net income.
Selling, general and administrative expenses were
$1,139,275 for the three months ended December 31, 2024, an increase of $89,585, compared to the three months ended December 31, 2023.
Selling, general and administrative expenses were $2,220,944 for the six months ended December 31, 2024, an increase of $147,573 compared
to the six months ended December 31, 2023. The increase in spending for the three months ended December 31, 2024 as compared to the same
period in 2023 relates mainly to the increase in employee compensation costs, outside selling costs related to non-employee sales representatives,
an increase in travel expenditures, an increase in outbound freight costs related to higher sales, offset in part, by a decrease in conference
expenses incurred during the period. The increase in spending for the six months ended December 31, 2024 as compared to the same period
in 2023 relates mainly to the increase in employee compensation costs, outside selling costs related to non-employee sales representatives,
an increase in outbound freight costs related to higher sales, and an increase in travel expenditures, offset in part, by a decrease in
conference expenses and general office supplies.
Other income for the three months ended December
31, 2024 and 2023 was $268,425 and $166,764, respectively. Other income for the six months ended December 31, 2024 and 2023 was $546,833
and $328,337, respectively. The increase for the three and six months ended December 31, 2024 is primarily due to the increase in interest
income resulting from an increase in investment securities, offset in part, by declining interest rates. Interest income is a function
of the level of investments and investment strategies that generally tend to be conservative.
The Company’s effective tax rate for the
three and six months ended December 31, 2024 was approximately 16.8% and 18.3% respectively, compared to 20.5% and 20.7% for the three
and six months ended December 31, 2023. The effective tax rate in fiscal 2025 and fiscal 2024 is less than the statutory tax rate mainly
due to the benefit received from ESOP dividends paid on allocated shares as well as the benefit from foreign derived intangible income,
offset in part, by the permanent difference for incentive stock option expense recorded for book purposes which is not deductible for
tax purposes. The effective tax rate in the three and six month period ended December 31, 2024 was lower than the prior year primarily
from a greater benefit derived from the ESOP dividends paid on allocated shares and the benefit derived from the exercise of incentive
stock options in the current period when compared to same period in the prior year.
Net income for the three months ended December
31, 2024 was $1,908,499 or $0.74 and $0.71 per share, basic and diluted, compared to net income of $1,795,370 or $0.73 and $0.72 per
share, basic and diluted, for the three months ended December 31, 2023. Net income for the six months ended December 31, 2024 was $3,506,816
or $1.37 and $1.32 per share, basic and diluted, compared to $2,889,914 or $1.17 and $1.16 per share, basic and diluted, for the six
months ended December 31, 2023. The increase in net income in the three months ended December 31, 2024 when compared to the same period
last year resulted primarily from the increase in interest income and lower provision for income taxes. The increase in net income in
the six months ended December 31, 2024 when compared to the same period last year resulted primarily from the increase in gross profit
and the increase in interest income, offset in part, by an increase in selling, general, and administrative expenses and an increase
in the provision for income taxes, all discussed above.
Liquidity and Capital Resources
The Company's working capital is an appropriate
indicator of the liquidity of its business, and during the past two fiscal years, the Company, when possible, has funded all of its operations
with cash flows resulting from operating activities and when necessary from its existing cash and investments. The Company did not borrow
any funds during the last two fiscal years. Management has available a $3,000,000 line of credit to help fund further growth or working
capital needs, if necessary, but does not anticipate the need for any borrowed funds in the foreseeable future. Contingent liabilities
on outstanding standby letters of credit agreements aggregated to zero at December 31, 2024 and 2023. The existing line of credit expires
February 28, 2025. Management anticipates that the line of credit will be renewed.
The Company's working capital as of December 31,
2024 and 2023 was approximately $40.2 million and approximately $33.1 million, respectively. The Company may at times be required to repurchase
shares at the ESOP participants’ request at fair market value. During the three and six months ended December 31, 2024 and 2023,
the Company did not repurchase any shares held by the ESOP. Under an existing authorization from the Company's Board of Directors, as
of December 31, 2024, management is authorized to purchase an additional $783,460 of Company stock.
The table below presents the summary of cash flow
information for the fiscal years indicated:
| |
Six Months Ended December 31, | |
| |
2024 | | |
2023 | |
Net cash provided by operating activities | |
$ | 6,766,541 | | |
$ | 5,939,155 | |
Net cash used in investing activities | |
| (2,935,397 | ) | |
| (4,402,562 | ) |
Net cash used in financing activities | |
| (155,636 | ) | |
| (682,415 | ) |
Net cash provided by operating activities fluctuates
between periods primarily as a result of differences in sales and net income, provision for income taxes, the timing of the collection
of accounts receivable, purchase of inventory, and payment of accounts payable. The increase in cash provided by operating activities
compared to the prior year primarily relates to an increase in contract liabilities for cash advances received from customers, the decrease
in prepaid expenses and other current assets, offset in part by a decrease in accounts payable. Net cash used in investing activities
decreased in the six months ended December 31, 2024 as compared to the same period in 2023 due to fewer additions to property, plant and
equipment and higher investment securities when compared to the same period last year. Cash used in financing activities for the six months
ended December 31, 2024 relates primarily to dividend payments on common stock, offset in part, by proceeds from the exercise of stock
options. Comparably, the dividends paid during the prior year were lower and cash received from stock option exercises in the prior year
was significantly lower. The Company currently believes that the cash flow generated from operations and when necessary, from cash and
cash equivalents will be sufficient to meet its long-term funding requirements for the foreseeable future.
During the six months ended December
31, 2024 and 2023, the Company expended $1,547,922 and $3,469,630, respectively, for plant improvements and new equipment, of which $1,346,396
and $3,292,313, respectively, was either reimbursed or eligible to be reimbursed under a not to exceed $7.4 million award received by
the Company. The award received by the Company is in support of facility and capital equipment upgrades for testing and qualification
for the United States Navy. This funding award is part of the Navy’s investment to improve and sustain the Surface Combatant Industrial
Base. The Company has budgeted approximately $500,000 for new equipment and plant improvements in fiscal year 2025, not reimbursable under
the funding awards received. A majority of these expenditures will be made to stay competitive in the marketplace and to meet the needs
of current contracts.
CAUTIONARY STATEMENT FOR PURPOSES OF
THE "SAFE HARBOR" PROVISIONS OF THE PRIVATE
SECURITIES LITIGATION REFORM ACT OF 1995
This report contains "forward-looking statements"
within the meaning of the Private Securities Litigation Reform Act of 1995. The terms "believe," "anticipate," "intend,"
"goal," "expect," and similar expressions may identify forward-looking statements. These forward-looking statements
represent the Company's current expectations or beliefs concerning future events. The matters covered by these statements are subject
to certain risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements,
including the Company's dependence on timely development, introduction and customer acceptance of new products, the impact of competition
and price erosion, supply and manufacturing constraints, potential new orders from customers, the impact of cyber or other security threats
or other disruptions to our business, the impact of inflationary pressures on the United States economy and our operations and other risks
and uncertainties. The foregoing list should not be construed as exhaustive, and the Company disclaims any obligation subsequently to
revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence
of anticipated or unanticipated events. The Company wishes to caution readers not to place undue reliance on any such forward-looking
statements, which speak only as of the date made.
Item 3. Quantitative and Qualitative Disclosures
About Market Risk
The Company is a smaller reporting company as
defined under Securities and Exchange Commission Rule 12b-2. Pursuant to the exemption available to smaller reporting company issuers
under Item 305 of Regulation S-K, quantitative and qualitative disclosures about market risk, the Company is not required to provide the
information for this item.
Item 4. Controls and Procedures
(a) The Company's management, with the participation
of the Company's Chief Executive Officer and Chief Financial Officer, carried out an evaluation of the effectiveness of our disclosure
controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) as of the end of the period
covered by this Quarterly Report on Form 10-Q. Based on such evaluation, our Chief Executive Officer and Chief Financial Officer have
concluded that our disclosure controls and procedures were effective as of the end of the period covered by this report.
(b) There have been no changes in our internal
controls over financial reporting during the period covered by this report that have materially affected, or are reasonably likely to
materially affect, our internal controls over financial reporting.
PART II: Other Information and Signatures
Currently, there are no matters pending against
the Company which could reasonably be expected to have a material adverse effect on our business, financial condition, results of operations
or cash flows.
| Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds |
| (c) | Securities Repurchased |
As of December 31, 2024 the Company can
repurchase up to $783,460 of its common stock pursuant to an existing authorization by the Board of Directors. During the quarter
ended December 31, 2024 no shares were repurchased.
| Item 3. | Defaults Upon Senior Securities |
None
| Item 4. | Mine Safety Disclosures |
Not applicable
None
S I G N A T U R E S
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
ESPEY MFG. & ELECTRONICS CORP. |
|
|
|
|
|
/s/ David O’Neil |
|
David O’Neil |
|
President and Chief Executive Officer |
|
|
|
/s/ Katrina Sparano |
|
Katrina Sparano |
|
Principal Financial Officer |
Date: February 12, 2025
0.33
0.33
0000033533
false
2025
Q2
--06-30
0000033533
2024-07-01
2024-12-31
0000033533
2025-02-10
0000033533
2024-12-31
0000033533
2024-06-30
0000033533
2024-10-01
2024-12-31
0000033533
2023-10-01
2023-12-31
0000033533
2023-07-01
2023-12-31
0000033533
us-gaap:CommonStockMember
2024-09-30
0000033533
us-gaap:AdditionalPaidInCapitalMember
2024-09-30
0000033533
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-09-30
0000033533
us-gaap:RetainedEarningsMember
2024-09-30
0000033533
us-gaap:TreasuryStockCommonMember
2024-09-30
0000033533
esp:UnearnedESOPSharesMember
2024-09-30
0000033533
2024-09-30
0000033533
us-gaap:RetainedEarningsMember
2024-10-01
2024-12-31
0000033533
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-10-01
2024-12-31
0000033533
us-gaap:CommonStockMember
2024-10-01
2024-12-31
0000033533
us-gaap:AdditionalPaidInCapitalMember
2024-10-01
2024-12-31
0000033533
us-gaap:TreasuryStockCommonMember
2024-10-01
2024-12-31
0000033533
us-gaap:CommonStockMember
2024-12-31
0000033533
us-gaap:AdditionalPaidInCapitalMember
2024-12-31
0000033533
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-12-31
0000033533
us-gaap:RetainedEarningsMember
2024-12-31
0000033533
us-gaap:TreasuryStockCommonMember
2024-12-31
0000033533
esp:UnearnedESOPSharesMember
2024-12-31
0000033533
us-gaap:CommonStockMember
2024-06-30
0000033533
us-gaap:AdditionalPaidInCapitalMember
2024-06-30
0000033533
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-06-30
0000033533
us-gaap:RetainedEarningsMember
2024-06-30
0000033533
us-gaap:TreasuryStockCommonMember
2024-06-30
0000033533
esp:UnearnedESOPSharesMember
2024-06-30
0000033533
us-gaap:RetainedEarningsMember
2024-07-01
2024-12-31
0000033533
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-07-01
2024-12-31
0000033533
us-gaap:CommonStockMember
2024-07-01
2024-12-31
0000033533
us-gaap:AdditionalPaidInCapitalMember
2024-07-01
2024-12-31
0000033533
us-gaap:TreasuryStockCommonMember
2024-07-01
2024-12-31
0000033533
us-gaap:CommonStockMember
2023-09-30
0000033533
us-gaap:AdditionalPaidInCapitalMember
2023-09-30
0000033533
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-09-30
0000033533
us-gaap:RetainedEarningsMember
2023-09-30
0000033533
us-gaap:TreasuryStockCommonMember
2023-09-30
0000033533
esp:UnearnedESOPSharesMember
2023-09-30
0000033533
2023-09-30
0000033533
us-gaap:RetainedEarningsMember
2023-10-01
2023-12-31
0000033533
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-10-01
2023-12-31
0000033533
us-gaap:AdditionalPaidInCapitalMember
2023-10-01
2023-12-31
0000033533
us-gaap:CommonStockMember
2023-12-31
0000033533
us-gaap:AdditionalPaidInCapitalMember
2023-12-31
0000033533
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-12-31
0000033533
us-gaap:RetainedEarningsMember
2023-12-31
0000033533
us-gaap:TreasuryStockCommonMember
2023-12-31
0000033533
esp:UnearnedESOPSharesMember
2023-12-31
0000033533
2023-12-31
0000033533
us-gaap:CommonStockMember
2023-06-30
0000033533
us-gaap:AdditionalPaidInCapitalMember
2023-06-30
0000033533
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-06-30
0000033533
us-gaap:RetainedEarningsMember
2023-06-30
0000033533
us-gaap:TreasuryStockCommonMember
2023-06-30
0000033533
esp:UnearnedESOPSharesMember
2023-06-30
0000033533
2023-06-30
0000033533
us-gaap:RetainedEarningsMember
2023-07-01
2023-12-31
0000033533
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-07-01
2023-12-31
0000033533
us-gaap:CommonStockMember
2023-07-01
2023-12-31
0000033533
us-gaap:AdditionalPaidInCapitalMember
2023-07-01
2023-12-31
0000033533
us-gaap:TreasuryStockCommonMember
2023-07-01
2023-12-31
0000033533
us-gaap:CertificatesOfDepositMember
2024-12-31
0000033533
us-gaap:MunicipalBondsMember
2024-12-31
0000033533
us-gaap:USTreasuryBillSecuritiesMember
2024-12-31
0000033533
us-gaap:CertificatesOfDepositMember
2024-06-30
0000033533
us-gaap:MunicipalBondsMember
2024-06-30
0000033533
us-gaap:USTreasuryBillSecuritiesMember
2024-06-30
0000033533
esp:NonQualifiedStockOptionsMember
2024-10-01
2024-12-31
0000033533
esp:NonQualifiedStockOptionsMember
2023-10-01
2023-12-31
0000033533
esp:NonQualifiedStockOptionsMember
2024-07-01
2024-12-31
0000033533
esp:NonQualifiedStockOptionsMember
2023-07-01
2023-12-31
0000033533
esp:IncentiveStockOptionMember
2024-12-31
0000033533
esp:NonQualifiedStockOptionsMember
2024-12-31
0000033533
esp:NonEmployeeDirectorsMember
esp:TwoThousandSeventeenPlanMember
2024-07-01
2024-12-31
0000033533
srt:MaximumMember
esp:NonEmployeeDirectorsMember
esp:TwoThousandSeventeenPlanMember
2024-07-01
2024-12-31
0000033533
srt:MaximumMember
esp:IndividualEmployeeMember
esp:TwoThousandSeventeenPlanMember
2024-07-01
2024-12-31
0000033533
us-gaap:EmployeeStockOptionMember
esp:TwoThousandSeventeenPlanMember
2024-07-01
2024-12-31
0000033533
us-gaap:EmployeeStockOptionMember
esp:TwoThousandSeventeenPlanMember
2024-12-31
0000033533
us-gaap:EmployeeStockOptionMember
2024-07-01
2024-12-31
0000033533
us-gaap:EmployeeStockOptionMember
2024-12-31
0000033533
esp:RestrictedStockPlanMember
esp:TwoThousandSevenPlanMember
2024-07-01
2024-12-31
0000033533
us-gaap:StockOptionMember
2024-07-01
0000033533
us-gaap:StockOptionMember
2024-07-01
2024-07-01
0000033533
us-gaap:StockOptionMember
2024-07-01
2024-12-31
0000033533
us-gaap:StockOptionMember
2024-12-31
0000033533
esp:UnitsDeliveredMember
esp:ASC606Member
2024-10-01
2024-12-31
0000033533
esp:UnitsDeliveredMember
esp:ASC606Member
2024-07-01
2024-12-31
0000033533
esp:UnitsDeliveredMember
esp:ASC606Member
2023-10-01
2023-12-31
0000033533
esp:UnitsDeliveredMember
esp:ASC606Member
2023-07-01
2023-12-31
0000033533
esp:MilestonesAchievedMember
esp:ASC606Member
2024-10-01
2024-12-31
0000033533
esp:MilestonesAchievedMember
esp:ASC606Member
2024-07-01
2024-12-31
0000033533
esp:MilestonesAchievedMember
esp:ASC606Member
2023-10-01
2023-12-31
0000033533
esp:MilestonesAchievedMember
esp:ASC606Member
2023-07-01
2023-12-31
0000033533
esp:ASC606Member
2024-12-31
0000033533
esp:ASC606Member
2024-06-30
0000033533
esp:ASC606Member
us-gaap:OrderOrProductionBacklogMember
2024-12-31
0000033533
esp:EmployeeStockOwnershipPlanMember
2024-06-30
2024-06-30
0000033533
esp:EmployeeStockOwnershipPlanMember
2024-10-01
2024-12-31
0000033533
esp:EmployeeStockOwnershipPlanMember
2023-10-01
2023-12-31
0000033533
esp:EmployeeStockOwnershipPlanMember
2024-07-01
2024-12-31
0000033533
esp:EmployeeStockOwnershipPlanMember
2023-07-01
2023-12-31
xbrli:shares
iso4217:USD
iso4217:USD
xbrli:shares
xbrli:pure
Pursuant to Rules
13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934,
Pursuant to Rules 13a-14(a) and 15d-14(a) under
the Securities Exchange Act of 1934,
Certification of the Chief Executive Officer pursuant
to 18 U.S.C. Section 1350,
In connection with this quarterly report of Espey
Mfg. & Electronics Corp. (the "Company") on Form 10-Q for the period ended December 31, 2024 as filed with the Securities
and Exchange Commission on the date hereof (the “report”), I, David O’Neil, President and Chief Executive Officer of
the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to
my knowledge:
Certification of the Principal Financial Officer
pursuant to 18 U.S.C. Section 1350,
In connection with this quarterly report of Espey
Mfg. & Electronics Corp. (the "Company") on Form 10-Q for the period ended December 31, 2024 as filed with the Securities
and Exchange Commission on the date hereof (the “report”), I, Katrina Sparano, Principal Financial Officer of the Company,
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge: